ClinConnect ClinConnect Logo
Search / Trial NCT05766761

Reducing Alcohol Exposed Pregnancies

Launched by NEW YORK UNIVERSITY · Mar 10, 2023

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Alcohol Drinking In Pregnancy Alcohol Exposed Pregnancies Alcohol Related Adverse Birth Outcomes

ClinConnect Summary

This clinical trial, called "Reducing Alcohol Exposed Pregnancies," is trying to find out if a special program can help pregnant women reduce their alcohol use. The researchers want to see if this program can lead to more women having negative tests for alcohol in their system during pregnancy and if it can help improve the health of their babies at birth. The program includes a computer-based tool that women can use at their own pace to learn about the effects of alcohol and how to cut back, along with support from a nurse who can answer questions and provide encouragement.

To participate in this study, women need to be at least 18 years old, be pregnant and less than 28 weeks along, and have recently consumed alcohol. If you're interested in joining, you would receive information and support designed to help you reduce your alcohol intake during pregnancy. It's important to know that this study is currently looking for participants, and it aims to provide valuable insights into improving both women's health and the health of their babies.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 18 years and above
  • Gestational age is 28 weeks or less
  • Recent alcohol use as assessed by self-report of alcohol use in the previous 30 days
  • Exclusion Criteria:
  • Under 18 years of age
  • Not pregnant or gestational age over 28 weeks
  • No recent alcohol use as assessed by self-report

About New York University

New York University (NYU) is a prestigious research institution renowned for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure and a diverse team of leading experts, NYU conducts cutting-edge research across various therapeutic areas, focusing on translating scientific discoveries into effective treatments. The university fosters collaboration among multidisciplinary teams and engages with a broad patient population, ensuring that its trials adhere to the highest ethical standards and regulatory requirements. NYU's dedication to excellence in research and education positions it as a key contributor to the advancement of healthcare and clinical practice.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Ralph DiClemente, PhD

Principal Investigator

New York University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials